Sustained Release Excipients Market By Product Type (Polymers, Gelatin, Minerals, Sugars, and Others), By Route of Administration (Oral, Subcutaneous, Transdermal, Intravenous, and Others), By Technology (Microencapsulation, Targeted Delivery, Wurster Technique, and Others), Region and Companies – Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2024-2033
- Published date: Nov 2024
- Report ID: 133841
- Number of Pages: 285
- Format:
-
keyboard_arrow_up
-
-
- Pfizer Inc Company Profile
- Merck KGaA Company Profile
- International Flavors & Fragrances, Inc.
- Gattefossé
- Evonik Industries
- Croda International Plc
- Biohaven Pharmaceutical Holding Company
- BASF SE Company Profile
- Ashland Global Holdings Inc. Company Profile
- settingsSettings
Our Clients
- 133841
- Nov 2024
Trusted by more than 17382 organizations globally
✖
Request a Sample Report
We'll get back to you as quickly as possible
|
Single User
$6,000
$3,999
USD / per unit
save 24%
|
Multi User
$8,000
$5,999
USD / per unit
save 28%
|
Corporate User
$10,000
$6,999
USD / per unit
save 32%
|
|
|---|---|---|---|
| e-Access | |||
| Report Library Access | |||
| Data Set (Excel) | |||
| Company Profile Library Access | |||
| Interactive Dashboard | |||
| Free Custumization | No | up to 10 hrs work | up to 30 hrs work |
| Accessibility | 1 User | 2-5 User | Unlimited |
| Analyst Support | up to 20 hrs | up to 40 hrs | up to 50 hrs |
| Benefit | Up to 20% off on next purchase | Up to 25% off on next purchase | Up to 30% off on next purchase |
| Buy Now ($ 3,999) | Buy Now ($ 5,999) | Buy Now ($ 6,999) |
